Can chronic hyperglycemia and insulin resistance affect brain glucose use, cerebral small vessels, and amyloid-beta clearance?

Metabolic dysfunction is relevant to brain health in later life through converging metabolic, microvascular, and amyloid-related pathways. For a 77-year-old man, the clearest evidence concerns chronic dysglycemia and cerebral small-vessel injury; effects on cerebral glucose metabolism and amyloid clearance are biologically credible but less definitive.

Clinical and neuroimaging evidence

• Diabetes was associated with cerebral hypometabolism in 749 nondemented older adults (adjusted OR 1.69, 95% CI 1.10–2.60); among those without diabetes, each 1% higher HbA1c was associated with greater odds of regional hypometabolism (OR 1.93, 95% CI 1.03–3.62). A review of 23 FDG-PET studies generally linked hyperglycemia or insulin resistance with lower regional or global uptake.
• The most established association is with cerebral small-vessel disease: a meta-analysis found diabetes associated with lacunes (OR 2.15, 95% CI 1.59–2.90) and white-matter hyperintensities (OR 1.66, 95% CI 1.49–1.84). Associations are stronger for diabetes/chronic hyperglycemia than for insulin resistance independent of blood pressure and body size.

Mechanistic interpretation

• Hyperglycemia can drive endothelial oxidative stress, reduced nitric-oxide availability, AGE–RAGE inflammatory signaling, and activation of polyol, hexosamine, and protein-kinase-C pathways. Endothelial/pericyte dysfunction, blood–brain-barrier disruption, impaired autoregulation, and reduced microvascular perfusion provide a coherent mechanism for white-matter injury.
• IDE degrades both insulin and amyloid-beta (Aβ). Excess insulin can compete for IDE and slow Aβ degradation in biochemical and cellular models; IDE-knockout mice have >50% lower brain Aβ degradation with increased cerebral Aβ.
• A small Finnish longitudinal cohort linked midlife insulin resistance to late-life amyloid-PET positivity (60.0% vs 33.3%; OR 3.0, 95% CI 1.1–8.9), consistent with—but not specifically proving—an IDE-mediated pathway.

Bottom line

• Chronic hyperglycemia is convincingly linked to cerebral small-vessel injury and plausibly contributes to brain hypometabolism and altered Aβ handling. Insulin resistance may amplify these processes, particularly through vascular and insulin/Aβ-metabolic mechanisms.